Several options open for Cordlife after failed takeover of StemLife


One of the cryo containers that store umbilical cord blood and bone marrow samples at the private cord blood bank StemLife Bhd in Kuala Lumpur. The samples are kept in the stacked metal boxes to the left of the cylinder.

PETALING JAYA: It will be interesting to see the next step Singapore-listed Cordlife Group Ltd will take after the failed takeover of StemLife Bhd.

At this point in time, Cordlife has updated the market that it had received valid acceptances that gave it an 89.88% equity interest in StemLife on Tuesday.

Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Business , Cordlife , Stemlife , privatisation

   

Next In Business News

Sin-Kung Logistics’ IPO public portion oversubscribed 26.5 times
Banking sector's 5.4% YTD loan growth in line with expectation for 2024
Maersk says Red Sea disruption will cut capacity by 15-20% in second quarter
Gold rises on Fed rate cut hopes, Middle East tensions
Oil climbs as Gaza tensions rise, Saudi Arabia hikes prices
Ways China must tread for seamless transition to new era
Home sweet home
Asia shares rally on China's gains, Fed cut bets; yen weakens
Seeking cover from middlemen
A real need for local giants

Others Also Read